# FDA 483 - POINT Biopharma USA Inc. - June 07, 2024

Source: https://www.globalkeysolutions.net/records/483/point-biopharma-usa-inc/530b5998-d13e-4471-9be4-0fce34b92ddf

> FDA 483 for POINT Biopharma USA Inc. on June 07, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: POINT Biopharma USA Inc.
- Inspection Date: 2024-06-07
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations III

## Related Documents

- [483 - 2024-06-07](https://www.globalkeysolutions.net/records/483/point-biopharma-usa-inc/1f72eb24-f80c-48b3-8d28-b652f2606bf0)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/muna-algharibeh/0f0dbd13-b36a-408d-8e42-4625f8de905d)
- [Matthew M. Schuckmann](https://www.globalkeysolutions.net/people/matthew-m-schuckmann/69dd0728-6b5d-41e7-834c-416e25a977dc)

Company: https://www.globalkeysolutions.net/companies/point-biopharma-usa-inc/f4a8cb71-7a5c-4407-a6c8-6765aacfb8da

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iii/45bc2d0d-d731-4955-aeb5-59aa0b76e4f0